The sampling and testing project will support the National Antimicrobial Resistance Monitoring System (NARMS) by identifying trends and emerging risks from drug-resistant foodborne bacteria. Findings will be used to create a model that can help predict and address antimicrobial resistance (AMR) mitigation strategies.
In light of World Antimicrobial Resistance (AMR) Awareness Week 2024, USDA has highlighted trends from its most recent National Antimicrobial Resistance Monitoring System (NARMS) report, covering 2021.
According to recent research from the U.S. Centers for Disease Control and Prevention (CDC), infections caused by Salmonella with antimicrobial resistance (AMR) only to clinically important antibiotics were not associated with poorer outcomes, suggesting that factors other than treatment failure may be important.
The National Antimicrobial Resistance Monitoring System (NARMS) recently published its 2020 Integrated Summary, which includes data providing phenotypic and genomic antimicrobial resistance (AMR) trends for Salmonella, Campylobacter, generic Escherichia coli, and Enterococcus isolated from retail meat and food-producing animals.
The U.S. Department of Agriculture’s Food Safety and Inspection Service (USDA’s FSIS) published a report that highlights multi-year trends for antimicrobial resistance among Salmonella from data collected by the National Antimicrobial Resistance Monitoring System (NARMS) during 2014–2019.
The U.S. Food and Drug Administration (FDA) recently released the National Antimicrobial Resistance Monitoring System Integrated Summary for 2019, which is a review of data gathered on the antimicrobial resistance (AMR) of several pathogens.
